Concurrently, both anti-Dsg1 and anti-Dsg3 antibody levels, as well as blood methoxyephedrine, decreased, suggesting that rituximab, in combination with other agents, was an effective therapeutic option for treating pemphigus [11]. Here, DSG1 is linked to pemphigus.